Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300
- PMID: 17220215
- PMCID: PMC2597984
- DOI: 10.1136/jmg.2006.046698
Genetic heterogeneity in Rubinstein-Taybi syndrome: delineation of the phenotype of the first patients carrying mutations in EP300
Abstract
Background: Rubinstein-Taybi syndrome (RSTS) is a congenital disorder characterised by growth retardation, facial dysmorphisms, skeletal abnormalities and mental retardation. Broad thumbs and halluces are the hallmarks of the syndrome. RSTS is associated with chromosomal rearrangements and mutations in the CREB-binding protein gene (CREBBP), also termed CBP, encoding the CREB-binding protein. Recently, it was shown that mutations in EP300, coding for the p300 protein, also cause RSTS. CBP and EP300 are highly homologous genes, which play important roles as global transcriptional coactivators.
Objective: To report the phenotype of the presently known patients with RSTS (n = 4) carrying germline mutations of EP300.
Results: The patients with EP300 mutations displayed the typical facial gestalt and malformation pattern compatible with the diagnosis of RSTS. However, three patients exhibited much milder skeletal findings on the hands and feet than typically observed in patients with RSTS.
Conclusions: Part of the clinical variability in RSTS is explained by genetic heterogeneity. The diagnosis of RSTS must be expanded to include patients without broad thumbs or halluces.
Conflict of interest statement
Competing interests: None.
Similar articles
-
Rubinstein-Taybi 2 associated to novel EP300 mutations: deepening the clinical and genetic spectrum.BMC Med Genet. 2018 Mar 5;19(1):36. doi: 10.1186/s12881-018-0548-2. BMC Med Genet. 2018. PMID: 29506490 Free PMC article.
-
Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome.Eur J Hum Genet. 2007 Aug;15(8):837-42. doi: 10.1038/sj.ejhg.5201791. Epub 2007 Feb 14. Eur J Hum Genet. 2007. PMID: 17299436
-
Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations.Am J Med Genet A. 2016 Dec;170(12):3069-3082. doi: 10.1002/ajmg.a.37940. Epub 2016 Sep 20. Am J Med Genet A. 2016. PMID: 27648933
-
Rubinstein-Taybi Syndrome and Epigenetic Alterations.Adv Exp Med Biol. 2017;978:39-62. doi: 10.1007/978-3-319-53889-1_3. Adv Exp Med Biol. 2017. PMID: 28523540 Free PMC article. Review.
-
Rubinstein-Taybi syndrome: clinical and molecular overview.Expert Rev Mol Med. 2007 Aug 20;9(23):1-16. doi: 10.1017/S1462399407000415. Expert Rev Mol Med. 2007. PMID: 17942008 Review.
Cited by
-
Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.Curr Pharm Des. 2013;19(28):5051-64. doi: 10.2174/13816128113199990382. Curr Pharm Des. 2013. PMID: 23448461 Free PMC article. Review.
-
Disorders of Transcriptional Regulation: An Emerging Category of Multiple Malformation Syndromes.Mol Syndromol. 2016 Oct;7(5):262-273. doi: 10.1159/000448747. Epub 2016 Sep 2. Mol Syndromol. 2016. PMID: 27867341 Free PMC article. Review.
-
Protein lysine acetylation by p300/CBP.Chem Rev. 2015 Mar 25;115(6):2419-52. doi: 10.1021/cr500452k. Epub 2015 Jan 16. Chem Rev. 2015. PMID: 25594381 Free PMC article. Review. No abstract available.
-
Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy.EMBO Mol Med. 2012 Jul;4(7):617-32. doi: 10.1002/emmm.201200234. Epub 2012 Apr 24. EMBO Mol Med. 2012. PMID: 22367739 Free PMC article.
-
Exome Sequencing Identification of EP300 Mutation in a Proband with Coloboma and Imperforate Anus: Possible Expansion of the Phenotypic Spectrum of Rubinstein-Taybi Syndrome.Mol Syndromol. 2015 Jul;6(2):99-103. doi: 10.1159/000375542. Epub 2015 Mar 3. Mol Syndromol. 2015. PMID: 26279656 Free PMC article.
References
-
- Hennekam R C. Rubinstein‐Taybi syndrome. Eur J Hum Genet 200614981–985. - PubMed
-
- Stevens C A, Hennekam R C, Blackburn B L. Growth in the Rubinstein‐Taybi syndrome. Am J Med Genet Suppl 1990651–55. - PubMed
-
- Rubinstein J H, Taybi H. Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 1963105588–608. - PubMed
-
- Petrij F, Giles R H, Dauwerse H G, Saris J J, Hennekam R C, Masuno M, Tommerup N, van Ommen G J, Goodman R H, Peters D J, Breuning M H. Rubinstein‐Taybi syndrome caused by mutations in the transcriptional co‐activator CBP. Nature 1995376348–351. - PubMed
-
- Roelfsema J H, White S J, Ariyurek Y, Bartholdi D, Niedrist D, Papadia F, Bacino C A, den Dunnen J T, van Ommen G J, Breuning M H, Hennekam R C, Peters D J. Genetic heterogeneity in Rubinstein‐Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 200576572–580. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous